These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1093 related items for PubMed ID: 24956265

  • 1. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO, Hecking M, Plischke M, Cejka D, Kieweg H, Haas M, Marculescu R, Hörl WH, Bieglmayer C, Sunder-Plassmann G.
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [Abstract] [Full Text] [Related]

  • 2. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
    Weinreich T, Ritz E, Passlick-Deetjen J.
    Perit Dial Int; 1996 Sep; 16(3):260-8. PubMed ID: 8761540
    [Abstract] [Full Text] [Related]

  • 3. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.
    Doumouchtsis K, Perrea D, Doumouchtsis S, Tziamalis M, Poulakou M, Vlachos I, Kostakis A.
    Ther Apher Dial; 2009 Feb; 13(1):49-55. PubMed ID: 19379170
    [Abstract] [Full Text] [Related]

  • 4. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
    Brandi L, Daugaard H, Nielsen PK, Jensen LT, Egsmose C, Olgaard K.
    Nephron; 1996 Feb; 74(1):89-103. PubMed ID: 8883025
    [Abstract] [Full Text] [Related]

  • 5. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
    Toussaint ND, Polkinghorne KR, Kerr PG, Somerville CA, Agar JW.
    Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
    [Abstract] [Full Text] [Related]

  • 6. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
    López Gavilanes E, González Parra E, de la Piedra C, Caramelo C, Rapado A.
    Miner Electrolyte Metab; 1994 Apr; 20(5):259-64. PubMed ID: 7700213
    [Abstract] [Full Text] [Related]

  • 7. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
    Hamano T, Oseto S, Fujii N, Ito T, Katayama M, Horio M, Imai E, Hori M.
    Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928
    [Abstract] [Full Text] [Related]

  • 8. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH, Huang TS, Hsieh SJ.
    Miner Electrolyte Metab; 1996 May; 22(4):219-23. PubMed ID: 8807625
    [Abstract] [Full Text] [Related]

  • 9. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H, Riedl M, Pietschmann P, Schmidt A, Schuster E, Kreuzer S, Kainberger F, Frisch H, Geyer G, Hörl WH, Mayer G, Luger A.
    J Nephrol; 2004 May; 17(1):87-94. PubMed ID: 15151263
    [Abstract] [Full Text] [Related]

  • 10. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years.
    Rauchenzauner M, Schmid A, Heinz-Erian P, Kapelari K, Falkensammer G, Griesmacher A, Finkenstedt G, Högler W.
    J Clin Endocrinol Metab; 2007 Feb; 92(2):443-9. PubMed ID: 17105843
    [Abstract] [Full Text] [Related]

  • 11. Sevelamer hydrochloride improves hyperphosphatemia in hemodialysis patients with low bone turnover rate and low intact parathyroid hormone levels.
    Kokuho T, Toya Y, Kawaguchi Y, Tamura K, Iwatsubo K, Dobashi Y, Nakazawa A, Takeda H, Iwatsubo M, Hirawa N, Yasuda G, Ohnishi T, Umemura S.
    Ther Apher Dial; 2007 Dec; 11(6):442-8. PubMed ID: 18028171
    [Abstract] [Full Text] [Related]

  • 12. Effect of haemodialysis on markers of bone turnover in children.
    Waller S, Ridout D, Rees L.
    Pediatr Nephrol; 2007 Apr; 22(4):586-92. PubMed ID: 17216258
    [Abstract] [Full Text] [Related]

  • 13. Effects of raloxifene on bone metabolism in postmenopausal women on chronic hemodialysis.
    Nagatoya K, Nishimoto K, Shibahara N, Takahashi T, Kanehara H, Ueno N, Yasuda H, Okada S, Ueda H, Hirai K, Inoue T, Hokusetsu Renal Osteodystrophy Study Group.
    Clin Exp Nephrol; 2015 Oct; 19(5):939-46. PubMed ID: 25504368
    [Abstract] [Full Text] [Related]

  • 14. Effects of lowering dialysate calcium concentration on mineral metabolism and hemodynamic parameters in hemodialysis patients.
    Alayoud A, El Kabbaj D, Benyahia M, Asseraji M, Zemraoui N.
    Iran J Kidney Dis; 2015 Mar; 9(2):132-7. PubMed ID: 25851292
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
    Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A, D'Haese PC, Drüeke TB, Du H, Manley T, Rojas E, Moe SM.
    Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
    [Abstract] [Full Text] [Related]

  • 16. Low calcium (1.25 mmol/L) dialysate can normalize relative hypoparathyroidism in CAPD patients with low bone turnover.
    Shigematsu T, Kawaguchi Y, Kubo H, Nakayama M, Kato N, Yamamoto H, Osaka N, Hayakawa H, Ogawa A, Sakai O.
    Adv Perit Dial; 1996 Apr; 12():250-6. PubMed ID: 8865914
    [Abstract] [Full Text] [Related]

  • 17. Secretion of parathyroid hormone oscillates depending on the change in serum ionized calcium during hemodialysis and may affect bone metabolism.
    Kitahara T, Ueki K, Kuroiwa T, Kaneko Y, Hiromura K, Nojima Y.
    Nephron Clin Pract; 2005 Apr; 101(1):c9-17. PubMed ID: 15886497
    [Abstract] [Full Text] [Related]

  • 18. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration.
    Al-Hejaili F, Kortas C, Leitch R, Heidenheim AP, Clement L, Nesrallah G, Lindsay RM.
    J Am Soc Nephrol; 2003 Sep; 14(9):2322-8. PubMed ID: 12937309
    [Abstract] [Full Text] [Related]

  • 19. Mineral bone disorder and osteoporosis in hemodialysis patients.
    Slouma M, Sahli H, Bahlous A, Laadhar L, Smaoui W, Rekik S, Gharsallah I, Sallami M, Moussa FB, Elleuch M, Cheour E.
    Adv Rheumatol; 2020 Feb 26; 60(1):15. PubMed ID: 32102689
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy.
    Salam S, Gallagher O, Gossiel F, Paggiosi M, Khwaja A, Eastell R.
    J Am Soc Nephrol; 2018 May 26; 29(5):1557-1565. PubMed ID: 29555831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.